Etoricoxib (Arcoxia) is a selective COX-2 inhibitor from Merck Co. Currently it is approved in levels of adverse events. Etoricoxib given at a dose of 120 mg is as effective or even better than other analgesics that are commonly used. canadian-pharmacyn.com cialis treatment prostate cancer